The world's leading automated proofreading software

MDR e-Labeling

Published By: Marc Chaillou

2 minutes read
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Table of Contents

Maximizing Consistency: Aligning e-IFUs with Printed Instructions for Use

The EU Medical Device Regulations (MDR) states any device manufacturer with a website must publish user information in electronic form. Other international jurisdictions already have similar requirements, all of which place new emphasis on e-Labeling as a discipline, which can be defined as the electronic publishing of labeling content, including Instructions for Use (IFU).

As medical device companies make labeling publicly available on their websites, the importance of clear, precise, and consistent content will increase. The ability to produce error-free labeling will thus become a competitive advantage for every medical device manufacturer.

Many companies, including Integra Lifesciences, Johnson & Johnson, Beckton Dickinson and Abbott Vascular, are already publishing their IFUs electronically. Most organizations upload a PDF version of artwork files used to print the insert leaflet. However, there is an issue from the perspective of a user or a patient: some of the folded broadsheet inserts, in multiple languages, are almost illegible online and impossible to print out in a format that can be read within a healthcare setting or on a home printer. There is nothing in published regulations to say this format cannot be used, and companies are obliged to ensure that online versions do not deviate from printed versions, but the MDR regulations does state that the IFUs must be clear, understandable and legible. These same requirements apply to e-Labeling and e-IFUs. Therefore, the online format really should be user friendly and reformatted for web consumption.

Streamline your IFU publishing process with TVT

To assist companies with this and ensure their labeling content is consistent across both printed and online versions, Schlafender Hase offers TVT (Text Verification Tool®), a proofreading tool that can compare printed formats with web-based versions to verify that they are accurate and compliant from a content perspective, regardless of the layout and format they are presented in.

As regulations change, products are updated, instructions need to be reviewed and errors rectified. These complexities will magnify, thus increasing the risk of discrepancies. TVT will provide a solution for a rolling verification of printed and online content, becoming pivotal to a highly efficient process of continuous compliance.

Do you want to find out more about how your proofreading life can be easier? Get in touch and we’ll tell you all about it.

Share this article

Marc Chaillou profile picture

Marc Chaillou

Head of Sales Europe and Global Strategic Projects, Schlafender Hase

Marc Chaillou is Head of Sales Europe and Global Strategic Projects at Schlafender Hase.

Learn More

Subscribe to our blog

Maximizing Consistency: Aligning e-IFUs with Printed Instructions for Use

The EU Medical Device Regulations (MDR) states any device manufacturer with a website must publish user information in electronic form. Other international jurisdictions already have similar requirements, all of which place new emphasis on e-Labeling as a discipline, which can be defined as the electronic publishing of labeling content, including Instructions for Use (IFU).

As medical device companies make labeling publicly available on their websites, the importance of clear, precise, and consistent content will increase. The ability to produce error-free labeling will thus become a competitive advantage for every medical device manufacturer.

Many companies, including Integra Lifesciences, Johnson & Johnson, Beckton Dickinson and Abbott Vascular, are already publishing their IFUs electronically. Most organizations upload a PDF version of artwork files used to print the insert leaflet. However, there is an issue from the perspective of a user or a patient: some of the folded broadsheet inserts, in multiple languages, are almost illegible online and impossible to print out in a format that can be read within a healthcare setting or on a home printer. There is nothing in published regulations to say this format cannot be used, and companies are obliged to ensure that online versions do not deviate from printed versions, but the MDR regulations does state that the IFUs must be clear, understandable and legible. These same requirements apply to e-Labeling and e-IFUs. Therefore, the online format really should be user friendly and reformatted for web consumption.

Streamline your IFU publishing process with TVT

To assist companies with this and ensure their labeling content is consistent across both printed and online versions, Schlafender Hase offers TVT (Text Verification Tool®), a proofreading tool that can compare printed formats with web-based versions to verify that they are accurate and compliant from a content perspective, regardless of the layout and format they are presented in.

As regulations change, products are updated, instructions need to be reviewed and errors rectified. These complexities will magnify, thus increasing the risk of discrepancies. TVT will provide a solution for a rolling verification of printed and online content, becoming pivotal to a highly efficient process of continuous compliance.

Do you want to find out more about how your proofreading life can be easier? Get in touch and we’ll tell you all about it.

Subscribe to our blog

Related Blogs

Why Automated Proofreading Matters in Biotech Scale-Ups

July 4, 2025

Schlafender Hase Team

Why Automated Proofreading Matters in Biotech Scale-Ups

In a fast-scaling biotech environment, you’re managing regulatory documents, clinical content, labeling, instructions for use, artwork, and important safety information. These aren’t just words on a page, they're the backbone of your product’s journey to patients, regulators, and partners. And every version must be accurate, consistent, and audit ready.

Why Automated Proofreading Matters in Biotech Scale-Ups
2 minutes read

Why Automated Proofreading Matters in Biotech Scale-Ups

In a fast-scaling biotech environment, you’re managing regulatory documents, clinical content, labeling, instructions for use, artwork, and important safety information. These aren’t just words on a page, they're the backbone of your product’s journey to patients, regulators, and partners. And every version must be accurate, consistent, and audit ready.

Frank Hessler - CEO of Schlafender Hase

June 30, 2025

Schlafender Hase Team

Schlafender Hase Announces Change in Executive Leadership

Founder & Chief Executive Officer Frank Hessler to join advisory board; André Cerbe to continue as sole Chief Executive Officer, supported by a strong Leadership team including Chief Technology Officer Karthikeyan Pandiyan.

Frank Hessler - CEO of Schlafender Hase
2 minutes read

Schlafender Hase Announces Change in Executive Leadership

Founder & Chief Executive Officer Frank Hessler to join advisory board; André Cerbe to continue as sole Chief Executive Officer, supported by a strong Leadership team including Chief Technology Officer Karthikeyan Pandiyan.

FDA's New Front-of-Package Nutrition Labeling

June 26, 2025

Schlafender Hase Team

FDA’s New Front-of-Package Nutrition Labeling

The FDA's proposed front-of-package nutrition labeling represents one of the most significant food labeling changes in decades. This article introduces the proposed rule, countries that have already implemented it, and explores the economic and health benefits.

FDA's New Front-of-Package Nutrition Labeling
2 minutes read

FDA’s New Front-of-Package Nutrition Labeling

The FDA's proposed front-of-package nutrition labeling represents one of the most significant food labeling changes in decades. This article introduces the proposed rule, countries that have already implemented it, and explores the economic and health benefits.